A fish oil compound called docosahexaenoic acid (DHA) worked just as well as the prescription diabetes drug vildagliptin at lowering blood sugar and improving insulin function in diabetic rats, according to a 2026 study published in Scientific Reports. In 80 laboratory rats, both DHA and vildagliptin reduced blood sugar by approximately 70% over four weeks, and DHA actually provided superior protection against cell damage from high blood sugar.
A new study from Gram Research analysis found that docosahexaenoic acid (DHA), a natural compound found in fish oil, performed just as well as vildagliptin, a prescription diabetes medication, at lowering blood sugar and improving insulin function in diabetic rats. Researchers tested both treatments over four weeks and discovered that DHA not only reduced high blood sugar levels but also protected the pancreas from damage by reducing harmful molecules called free radicals. The study suggests that DHA might offer a natural alternative or complement to traditional diabetes drugs, though more research in humans is needed before drawing firm conclusions about its use in people.
Key Statistics
A 2026 study of 80 diabetic rats found that docosahexaenoic acid (DHA) reduced blood sugar from 449.9 mg/L to 137.10 mg/L—a 70% reduction comparable to the prescription drug vildagliptin, which reduced it to 131.40 mg/L.
In the same 2026 rat study, DHA increased protective antioxidant enzymes by 15-26% more than vildagliptin, including a 26% greater increase in superoxide dismutase activity, suggesting superior cellular protection.
A 2026 research article in Scientific Reports found that both DHA and vildagliptin improved insulin resistance markers (HOMA-IR) by approximately 40%, dropping from 4.26 to approximately 2.5 in diabetic rats over four weeks.
The 2026 study showed that DHA treatment restored normal pancreatic tissue structure damaged by diabetes and activated key insulin-sensitivity genes (SIRT1, Akt, and PI3K) at levels comparable to prescription vildagliptin treatment.
The Quick Take
- What they studied: Whether a fish oil compound called DHA could lower blood sugar and improve insulin function as effectively as a prescription diabetes medication called vildagliptin
- Who participated: Eighty male laboratory rats divided into five groups: healthy rats, diabetic rats, and diabetic rats treated with either DHA, vildagliptin, or both
- Key finding: Both DHA and vildagliptin reduced blood sugar by about 70% and worked equally well at improving how the body uses insulin. DHA was actually slightly better at protecting cells from damage caused by high blood sugar
- What it means for you: This research suggests DHA from fish oil might help manage diabetes, but this study was done in rats, not humans. Anyone with diabetes should talk to their doctor before making changes to their treatment plan
The Research Details
Scientists created diabetes in laboratory rats using a high-fat diet and a chemical injection to mimic type 2 diabetes in humans. They then divided 80 rats into five groups: one group stayed healthy as a control, and four groups had diabetes. Two diabetic groups received treatments—one got vildagliptin (a common diabetes drug) and one got DHA (a fish oil compound)—for four weeks. A third diabetic group got both treatments, and a fourth got DHA without diabetes to see if it had any effects on healthy animals.
The researchers measured blood sugar levels, insulin production, and markers of cell damage in the pancreas (the organ that makes insulin). They also looked at genes that control how cells respond to insulin and how well the pancreas tissue looked under a microscope.
This type of study is called a controlled animal experiment because the scientists carefully controlled which rats got which treatment and compared the results between groups.
Animal studies like this help scientists understand how new treatments might work before testing them in humans. By using rats with diabetes similar to human type 2 diabetes, researchers can see if natural compounds like DHA might be safer or more effective alternatives to prescription drugs. This research is important because it looks at the actual biological pathways (the SIRT1/Akt/PI3K pathway) that control insulin sensitivity, not just whether blood sugar goes down.
This study was published in Scientific Reports, a peer-reviewed scientific journal, which means other experts reviewed the work before publication. The researchers used a control group of healthy rats for comparison, which strengthens the findings. However, this is an animal study, so results may not directly apply to humans. The study size of 80 rats is reasonable for this type of research. The findings were statistically significant (p < 0.001), meaning the results were very unlikely to happen by chance.
What the Results Show
Both DHA and vildagliptin dramatically reduced blood sugar levels in diabetic rats. Blood sugar dropped from 449.9 mg/L in untreated diabetic rats to 131.40 mg/L with vildagliptin and 137.10 mg/L with DHA—a reduction of about 70% in both cases. Both treatments also increased insulin levels in the blood, showing that the pancreas was working better.
A key measure of insulin resistance called HOMA-IR dropped significantly with both treatments, from 4.26 in diabetic rats to 2.52 with vildagliptin and 2.55 with DHA. This means both treatments helped the body use insulin more effectively.
Both treatments also improved cholesterol and triglyceride levels, which are often abnormal in people with diabetes. This suggests benefits beyond just blood sugar control.
When researchers looked at the pancreas tissue under a microscope, both treatments restored normal tissue structure that had been damaged by diabetes, and both activated important genes (SIRT1, Akt, and PI3K) that control insulin sensitivity.
DHA showed some advantages over vildagliptin in protecting cells from oxidative stress (damage from harmful molecules). DHA increased protective molecules like glutathione by 15% more than vildagliptin, and increased antioxidant enzymes like catalase and superoxide dismutase by 17% and 26% more, respectively. This suggests DHA may have additional protective effects on pancreatic cells beyond just improving insulin function. Interestingly, DHA given to healthy rats had no negative effects, suggesting it’s well-tolerated even in non-diabetic animals.
This research builds on previous studies showing that omega-3 fatty acids like DHA can help with blood sugar control and reduce inflammation. The novel finding here is that DHA appears to work through the same biological pathway (SIRT1/Akt/PI3K) as vildagliptin, a modern diabetes drug. Previous research suggested DHA might help with diabetes, but this study directly compares it head-to-head with an approved medication, showing comparable effectiveness. The focus on oxidative stress and antioxidant protection adds new understanding of how DHA might benefit diabetic patients.
This study was conducted only in rats, not humans, so results may not directly translate to people with diabetes. The treatment period was only four weeks, which is relatively short—we don’t know if benefits would continue or change over months or years. The study doesn’t tell us what dose of DHA would be appropriate for humans or whether it would work as well in people as it did in rats. Additionally, the study only looked at type 2 diabetes, not type 1 diabetes. The researchers didn’t test DHA combined with other diabetes medications, which many people with diabetes actually take.
The Bottom Line
Based on this animal research, DHA shows promise as a potential diabetes management tool, but it should not replace prescribed diabetes medications without medical supervision. People with diabetes interested in fish oil supplements should discuss this with their doctor before starting. The evidence is currently moderate strength because it comes from animal studies; human clinical trials would be needed to make stronger recommendations. For general health, the American Heart Association already recommends omega-3 fatty acids like DHA for heart health, which may provide additional benefits for people with diabetes.
People with type 2 diabetes or those at risk for diabetes may find this research interesting, as it suggests a natural compound could help manage blood sugar. Healthcare providers treating diabetes should be aware of this research as it may inform discussions about complementary approaches. People with heart disease should care about this because DHA improved cholesterol levels. However, people with type 1 diabetes, those taking blood thinners, or those with fish allergies should consult their doctor before using DHA supplements.
In this rat study, benefits appeared within four weeks of treatment. In humans, omega-3 supplements typically take 4-12 weeks to show measurable effects on blood sugar and cholesterol. However, individual responses vary significantly, and longer-term studies would be needed to understand sustained benefits and optimal dosing.
Frequently Asked Questions
Can fish oil help with type 2 diabetes?
Research suggests omega-3 fatty acids like DHA from fish oil may help improve blood sugar control and insulin sensitivity. A 2026 rat study found DHA reduced blood sugar by 70% and worked as well as a prescription diabetes drug. However, human studies are limited, so fish oil should complement, not replace, prescribed diabetes medications.
Is DHA better than diabetes medications?
In rats, DHA performed comparably to vildagliptin, a prescription diabetes drug, and showed slightly better antioxidant protection. However, this was an animal study. Human research is needed before concluding DHA equals prescription medications. Always consult your doctor before changing diabetes treatment.
How much DHA should I take for diabetes?
This rat study used 300 mg/kg body weight, but human-equivalent doses haven’t been established. Typical fish oil supplements contain 500-2000 mg DHA daily. Discuss appropriate dosing with your healthcare provider, as individual needs vary based on diet, medications, and health status.
How long does it take for fish oil to lower blood sugar?
In the rat study, benefits appeared within four weeks. In humans, omega-3 supplements typically require 4-12 weeks to show measurable effects on blood glucose and cholesterol. Individual responses vary, and longer-term studies would help clarify realistic timelines.
Are there side effects from taking DHA supplements?
The 2026 study found DHA was well-tolerated in healthy rats with no adverse effects. In humans, fish oil supplements are generally safe but may cause mild side effects like fishy aftertaste, nausea, or blood thinning at high doses. Discuss with your doctor, especially if taking blood thinners.
Want to Apply This Research?
- Track daily DHA intake (in milligrams) alongside fasting blood glucose readings to identify personal patterns. Log the source (fish oil supplement, fatty fish consumption, or both) and note any changes in energy levels or blood sugar stability over 8-12 weeks.
- Add a daily fish oil supplement or increase consumption of DHA-rich foods like salmon, mackerel, or sardines. Start with a modest dose (500-1000 mg DHA daily) and track blood sugar response. Use the app to set reminders for consistent daily intake and log any side effects.
- Establish a baseline of fasting blood glucose and HbA1c (if available) before starting DHA supplementation. Check blood glucose weekly and record in the app. After 8-12 weeks, compare trends to baseline. If using continuous glucose monitoring, track average glucose levels and time in target range. Share data with your healthcare provider to assess whether DHA is contributing to improved control.
This article discusses animal research and should not be interpreted as medical advice for treating human diabetes. The study was conducted in laboratory rats, and results may not directly apply to humans. Anyone with diabetes or considering DHA supplementation should consult their healthcare provider before making changes to their treatment plan. DHA supplements should not replace prescribed diabetes medications without medical supervision. This research is preliminary and requires human clinical trials before firm recommendations can be made. Always discuss supplement use with your doctor, especially if you take blood thinners or have fish allergies.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.